Mechanistic insight into the functional and toxic effects of Strophanthidin in the failing human myocardium

European Journal of Heart Failure

Volumn 9, Issue 11, 2007, Pages 1086-1094

  von Lewinski, Dirk ^a,b   Bisping, Egbert ^a,b   Elgner, Andreas ^a   Kockskämper, Jens ^a,b   Pieske, Burkert ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Arrhythmias; Calcium; Cardiac glycosides; Contractile function; Human myocardium

Indexed keywords

5 [1 (3,4 DIMETHOXYBENZOYL) 1,2,3,4 TETRAHYDRO 6 QUINOLYL] 3,6 DIHYDRO 6 METHYL 2H 1,3,4 THIADIAZIN 2 ONE; BETA ADRENERGIC RECEPTOR; CALCIUM; ISOPRENALINE; SODIUM; STROPHANTHIDIN;

ADULT; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CARDIOTOXICITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIASTOLE; FEMALE; HEART CELL CULTURE; HEART FAILURE; HEART LEFT VENTRICLE CONTRACTILITY; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE PERFORMANCE; HEART MUSCLE CELL; HUMAN; HUMAN TISSUE; INOTROPISM; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SODIUM BLOOD LEVEL;

CARDIOTONIC AGENTS; DIASTOLE; FEMALE; HEART FAILURE; HUMANS; ISOPROTERENOL; MALE; MIDDLE AGED; MYOCARDIAL CONTRACTION; SODIUM-CALCIUM EXCHANGER; STROPHANTHIDIN; SYSTOLE;

EID: 35448953432     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2007.08.004     Document Type: Article

References (30)

1. Swedberg K., Cleland J., Dargie H., Drexler H., Follath F., Komajda M., et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 1115-1140
2. Nieminen M.S., Bohm M., Cowie M.R., Drexler H., Filippatos G.S., Jondeau G., et al. Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the Task Force on Acute Heart Failure of the European Society of Cardiology. Eur Heart J 26 (2005) 384-416
3. Kass R.S., Lederer W.J., Tsien R.W., and Weingart R. Role of calcium ions in transient inward currents and aftercontractions induced by strophanthidin in cardiac Purkinje fibres. J Physiol 281 (1978) 187-208
4. Norgaard A., Bagger J.P., Bjerregaard P., Baandrup U., Kjeldsen K., and Thomsen P.E. Relation of left ventricular function and Na,K-pump concentration in suspected idiopathic dilated cardiomyopathy. Am J Cardiol 61 (1988) 1312-1315
5. Shamraj O.I., Grupp I.L., Grupp G., Melvin D., Gradoux N., Kremers W., et al. Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovasc Res 27 (1993) 2229-2237
6. Bers D.M., and Bridge J.H. Effect of acetylstrophanthidin on twitches, microscopic tension fluctuations and cooling contractures in rabbit ventricle. J Physiol 404 (1988) 53-69
7. Isenberg G. Contractility of isolated bovine ventricular myocytes is enhanced by intracellular injection of cardioactive glycosides. Evidence for an intracellular mode of action. Basic Res Cardiol 79 Suppl (1984) 56-71
8. McGarry S.J., Scheufler E., and Williams A.J. Effect of R56865 on cardiac sarcoplasmic reticulum function and its role as an antagonist of digoxin at the sarcoplasmic reticulum calcium release channel. Br J Pharmacol 114 (1995) 231-237
9. Nishio M., Ruch S.W., Kelly J.E., Aistrup G.L., Sheehan K., and Wasserstrom J.A. Ouabain increases sarcoplasmic reticulum calcium release in cardiac myocytes. J Pharmacol Exp Ther 308 (2004) 1181-1190
10. Ahmed A., Rich M.W., Love T.E., Lloyd-Jones D.M., Aban I.B., Colucci W.S., et al. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur Heart J 27 (2006) 178-186
11. Rathore S.S., Curtis J.P., Wang Y., Bristow M.R., and Krumholz H.M. Association of serum digoxin concentration and outcomes in patients with heart failure. JAMA 289 (2003) 871-878
12. Pieske B., Sutterlin M., Schmidt-Schweda S., Minami K., Meyer M., Olschewski M., et al. Diminished post-rest potentiation of contractile force in human dilated cardiomyopathy. Functional evidence for alterations in intracellular Ca2+ handling. J Clin Invest 98 (1996) 764-776
13. Pieske B., Maier L.S., Bers D.M., and Hasenfuss G. Ca2+ handling and sarcoplasmic reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ Res 85 (1999) 38-46
14. Pieske B., Maier L.S., Piacentino III V., Weisser J., Hasenfuss G., and Houser S. Rate dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation 106 (2002) 447-453
15. Endoh M., and Blinks J.R. Actions of sympathomimetic amines on the Ca2+ transients and contractions of rabbit myocardium: reciprocal changes in myofibrillar responsiveness to Ca2+ mediated through alpha- and beta-adrenoceptors. Circ Res 62 (1988) 247-265
16. Nishio M., Ruch S.W., and Wasserstrom J.A. Positive inotropic effects of ouabain in isolated cat ventricular myocytes in sodium-free conditions. Am J Physiol Heart Circ Physiol 283 (2002) H2045-H2053
17. Despa S., Bossuyt J., Han F., Ginsburg K.S., Jia L., Kutchai H., et al. Phospholemman-phosphorylation mediates the {beta}-adrenergic effects on Na/K pump function in cardiac myocytes. Circ Res 97 3 (2005) 252-259
18. Santana L.F., Gomez A.M., and Lederer W.J. Ca2+ flux through promiscuous cardiac Na+ channels: slip-mode conductance. Science 279 (1998) 1027-1033
19. Piacentino III V., Gaughan J.P., and Houser S.R. L-type Ca(2+) currents overlapping threshold Na(+) currents: could they be responsible for the "slip-mode" phenomenon in cardiac myocytes?. Circ Res 90 (2002) 435-442
20. Hambarchian N., Brixius K., Lu R., Muller-Ehmsen J., and Schwinger R.H. Ouabain increases myofibrillar Ca2+ sensitivity but does not influence the Ca2+ release in human skinned fibres. Eur J Pharmacol 492 (2004) 225-231
21. Pieske B., Schlotthauer K., Schattmann J., Beyersdorf F., Martin J., Just H., et al. Ca(2+)-dependent and Ca(2+)-independent regulation of contractility in isolated human myocardium. Basic Res Cardiol 92 Suppl 1 (1997) 75-86
22. Bossuyt J., Ai X., Moorman J.R., Pogwizd S.M., and Bers D.M. Expression and phosphorylation of the na-pump regulatory subunit phospholemman in heart failure. Circ Res 97 (2005) 558-565
23. Muller-Ehmsen J., Frank K., Brixius K., and Schwinger R.H. Increase in force of contraction by activation of the Na+/Ca(2+)-exchanger in human myocardium. Br J Clin Pharmacol 43 (1997) 399-405
24. Lehnart S.E., Wehrens X.H., and Marks A.R. Calstabin deficiency, ryanodine receptors, and sudden cardiac death. Biochem Biophys Res Commun 322 (2004) 1267-1279
25. Schwinger R.H., Bohm M., Schmidt U., Karczewski P., Bavendiek U., Flesch M., et al. Unchanged protein levels of SERCA II and phospholamban but reduced Ca2+ uptake and Ca(2+)-ATPase activity of cardiac sarcoplasmic reticulum from dilated cardiomyopathy patients compared with patients with nonfailing hearts. Circulation 92 (1995) 3220-3228
26. Schwinger R.H., Bohm M., and Erdmann E. Effectiveness of cardiac glycosides in human myocardium with and without "downregulated" beta-adrenoceptors. J Cardiovasc Pharmacol 15 (1990) 692-697
27. Lehnart S.E., Wehrens X.H., Kushnir A., and Marks A.R. Cardiac ryanodine receptor function and regulation in heart disease. Ann N Y Acad Sci 1015 (2004) 144-159
28. Maier L.S., Schwan C., Schillinger W., Minami K., Schutt U., and Pieske B. Gingerol, isoproterenol and ouabain normalize impaired post-rest behavior but not force-frequency relation in failing human myocardium. Cardiovasc Res 45 (2000) 913-924
29. Houser S.R. Can novel therapies for arrhythmias caused by spontaneous sarcoplasmic reticulum Ca2+ release be developed using mouse models?. Circ Res 96 (2005) 1031-1032
30. 2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 99 (1999) 641-648